US and EMEA name officers participating in staff exchange programme
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration and the European Medicines Agency have reached a milestone in their international collaboration efforts. At the Drug Information Association’s 45th annual meeting in San Diego, US, on 24 June, the regulatory authorities named two officials that they have chosen to participate in the first-ever permanent staff exchange arrangement between the agencies. Karen Finn reports.